Find your path to Oliver
455 people in our graph share verified history with Oliver — schools, employers, funds. One of them is your warm intro.
Matt CherianunlockedOliver: together at London Business School (2012)
×7Oliver: together at Stanford University Graduate School of Business
×4Oliver: together at London Business School
About
Oliver Stauch is Co-Founder and Chief Operating Officer of Eyconis, Inc., an ophthalmology spinoff of Ascendis Pharma focused on long-acting drug delivery products for retinal diseases. He has more than 20 years of experience in pharmaceutical product development, technical operations, and business operations, including leadership roles across Europe, Japan, and the United States.
Executive at Eyconis
Intro paths
→
In turn, Oliver can intro founders to Eyconis's investors below.
Experience
- Eyconis, IncCo-Founder & Chief Operating Officercurrent2024 — presentSan Francisco Bay Area
- Ascendis PharmaHead of Ophthalmology2023 — 2024Palo Alto, California
- Ascendis PharmaVP, Head Product Development (US)2017 — 2024Palo Alto, California
- Atropos Therapeutics Inc.Advisory Board Member2018 — 2023San Francisco Bay Area
- GenentechGlobal Head, Business Excellence and Learning & Development (Technical Development Operations)2017South San Francisco, California
- GenentechResearch Project Team Leader (PTL)2013 — 2017
- GenentechHead Pharmaceutical Processing and Technology Development2013 — 2016
- RocheHead Pharmaceutical and Analytical R&D Biologics and Parenterals2010 — 2013Basel Area, Switzerland
- RocheHead Biologics Strategy Group2007 — 2010Basel, Switzerland
- RocheGlobal Technical Leader2007 — 2010Basel Area, Switzerland
- RocheDepartmental Project Leader2003 — 2006
- Chugai Pharmaceutical Co. Ltd.Senior Team Leader2006 — 2007Tokyo Area, Japan
- FluidsCompany Founder & Owner2000 — 2003Freiburg Area, Germany
Skills & more
Drug Discovery18Clinical Development25Biotechnology42Drug Delivery8Technology Transfer18Regulatory Affairs9Oncology8Drug Development35Lifesciences3Pharmacology5CMO management1Project Management2
+12 more
People DevelopmentPharmaceuticsR&DGLPPharmaceutical ResearchPharmacokineticsRegulatory SubmissionsTherapeutic AreasPharmaceutical IndustryCROINDCMCLanguages English · French · German
From Oliver's professional profile.
Frequently asked questions
- Who is Oliver Stauch?
- Oliver Stauch is Co-Founder and Chief Operating Officer of Eyconis, Inc., an ophthalmology spinoff of Ascendis Pharma focused on long-acting drug delivery products for retinal diseases. He has more than 20 years of experience in pharmaceutical product development, technical operations, and business operations, including leadership roles across Europe, Japan, and the United States.
- Where does Oliver Stauch work?
- Oliver Stauch is Executive at Eyconis.
- Where did Oliver Stauch go to school?
- Oliver Stauch studied at Stanford University Graduate School of Business (Corporate Innovation); London Business School (Global Leaders Program (Roche Corporate)); The University of Freiburg (Doctor of Philosophy (PhD), Pharmacy).
Same school
Also attended Stanford University Graduate School of Business2,000
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberPeter FentonGeneral Partner at BenchmarkDavid SzeAdvisory Partner at GreylockKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Hunter WalkCo-founder & Partner at HomebrewScott SandellExecutive Chairman & Chief Investment Officer at NEA
+ 1,994 more
Also attended London Business School906
Patrick ClaessenPartner at Cottonwood Technology FundDominic JacquessonInvestor at Index VenturesSandra SchwarzerInvestor at Index VenturesMatt CherianVenture Partner at Monta Vista CapitalAkshat GoenkaInvestor at Moonfire VenturesGiuseppe IademarcoHead of Global Partnership at P101 Ventures
+ 900 more
Also attended The University of Freiburg78
Ruth Foxe BladerInvestor at Citrine VentureDr. Elias Börgmann-DehinaGeneral Counsel & Portfolio Manager at HeadlineJens LapinskiFounding Partner at Angel InvestChristina UlardicPartner at Astanor VenturesMaik FechnerVenture Partner at Blockchain Founders CapitalJan BeckerInvestment Team at 10x Founders
+ 72 more
Shared employers
Also worked at Eyconis, Inc2
Also worked at Ascendis Pharma8
Jonathan LeffExecutive Partner, Private Equity at Sofinnova VenturesAlbert ChaManaging Partner at Frazier Life SciencesErik SteffensenExpert advisor at VÅR VenturesJan Møller MikkelsenPresident at Ascendis Pharma A/SMark BachChief Medical Officer at GentiBioMartin AusterExecutive Officer at Ascendis Pharma
+ 2 more
Also worked at Genentech245
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 239 more














































